Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A poly(amidoamine) (
PAA
) copolymer with beta-cyclodextrin was obtained by polyaddition reaction of 6-deoxy-6-amino-beta-cyclodextrin (beta-CD-NH(2)) and 2-methylpiperazine to 2,2-bis(acrylamido)acetic acid in aqueous medium. This beta-CD/
PAA
copolymer bears beta-CD units along the macromolecular chain, is water-soluble and non-cytotoxic. The complexing capacity of beta-CD/
PAA
was determined using an antiviral drug,
Acyclovir
, as a model of poorly water-soluble drug. Complex formation was confirmed by means of DSC and FTIR analyses. beta-CD/
PAA
can solubilize up to 11% w/w of
Acyclovir
notably increasing the aqueous solubility of the drug. The in vitro release studies showed the dependence of
Acyclovir
release rate on the solution pH. The antiviral activity of
Acyclovir
beta-CD/
PAA
complex was evaluated against herpes simplex virus type I in cell cultures. The
Acyclovir
beta-CD/
PAA
complex exhibited a higher antiviral activity than the free drug.
...
PMID:Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer. 1807 13